AlphaFold predicted structure
ATN1 · P54259

Mean pLDDT
48.3/ 100
Very low
1,190 residues
Confidence breakdown
- Very high(≥ 90)3%
- Confident(70–90)10%
- Low(50–70)17%
- Very low(< 50)70%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
atrophin 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAdult onset dystonia, chorea or related movement disorder
OtherAdult onset neurodegenerative disorder
OtherAtaxia and cerebellar anomalies - narrow panel
OtherBrain channelopathy
Other+5 more panels — install the extension to see the full list inline on any page.
congenital hypotonia, epilepsy, developmental delay, and digital anomalies
dentatorubral-pallidoluysian atrophy
Dentatorubral pallidoluysian atrophy
hereditary disease
Neck pain
Intellectual disability
Hydrocephalus with stenosis of the aqueduct of Sylvius
X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
Huntington disease
Leber congenital amaurosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Atrophin-1
Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats
ATN1 · P54259

Mean pLDDT
48.3/ 100
Very low
1,190 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0